hypercapnia/panax notoginseng

鏈接已保存到剪貼板

文章臨床試驗專利權

選擇排序類型

2 結果

Ginsenoside Rg1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of p38.

只有註冊用戶可以翻譯文章

登陸註冊

BACKGROUND Pulmonary arterial hypertension (PAH) is a fatal disease characterized by increased pulmonary arteriolar resistance. Pulmonary vasoconstriction has been proved to play a significant role in PAH. We previously reported that Panax notoginseng saponins (PNS) might attenuate hypoxia and

Notoginsenoside R1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of ERK.

只有註冊用戶可以翻譯文章

登陸註冊

Pulmonary arterial hypertension (PAH) is a disease of the small pulmonary arteries characterized by increased vascular resistance. Pulmonary vasoconstriction has been proven to play a pivotal role in PAH. We have previously hypothesized that Panax notoginseng saponins (PNS) might attenuate

加入我們的臉書專頁

Herbal & Natural Medicine

科學支持的最完整的草藥數據庫

支持55種語言
科學支持的草藥療法
通過圖像識別草藥
交互式GPS地圖-在位置標記草藥（即將推出）
閱讀與您的搜索相關的科學出版物
通過藥效搜索藥草
組織您的興趣並及時了解新聞研究，臨床試驗和專利

輸入症狀或疾病，並閱讀可能有用的草藥，輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究